[Metindol suppositories in the treatment of progressive polyarthritis]. 1980

K Pavelka, and O Vojtísek

UI MeSH Term Description Entries
D007213 Indomethacin A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. Amuno,Indocid,Indocin,Indomet 140,Indometacin,Indomethacin Hydrochloride,Metindol,Osmosin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D013488 Suppositories Medicated dosage forms that are designed to be inserted into the rectal, vaginal, or urethral orifice of the body for absorption. Generally, the active ingredients are packaged in dosage forms containing fatty bases such as cocoa butter, hydrogenated oil, or glycerogelatin that are solid at room temperature but melt or dissolve at body temperature. Rectal Suppositories,Vaginal Suppositories,Vaginal Suppository,Suppositories, Rectal,Suppositories, Vaginal,Suppository, Vaginal

Related Publications

K Pavelka, and O Vojtísek
December 1954, Vie medicale (Paris, France : 1920),
K Pavelka, and O Vojtísek
July 1962, Revista espanola de reumatismo y enfermedades osteoarticulares,
K Pavelka, and O Vojtísek
April 1983, Vnitrni lekarstvi,
K Pavelka, and O Vojtísek
January 1971, Zeitschrift fur Rheumaforschung,
K Pavelka, and O Vojtísek
August 1975, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
K Pavelka, and O Vojtísek
May 1973, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
K Pavelka, and O Vojtísek
June 1956, El Dia medico,
K Pavelka, and O Vojtísek
January 1976, Acta medica Austriaca. Supplement,
K Pavelka, and O Vojtísek
January 1963, Chirurgia narzadow ruchu i ortopedia polska,
Copied contents to your clipboard!